Understanding how cells repair damaged DNA caused by environmental pollutants and cancer treatments

Repair of DNA ends with adducts

NIH-funded research University of Texas Hlth Science Center · NIH-11035166

This study looks at how our cells fix DNA damage caused by things like pollution and cancer treatments, focusing on a specific type of damage that can lead to serious problems if not repaired, and it aims to help improve cancer treatments and lessen their side effects.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center NIH-funded
Lab location1 site (San Antonio, United States)
Project IDNIH-11035166 on NIH RePORTER

What this research studies

This research investigates how cells repair DNA damage caused by environmental pollutants and anti-cancer drugs, specifically focusing on DNA-protein crosslinks that can lead to serious genetic issues if not addressed. The study employs genetic and biochemical methods to explore the role of specific enzymes, such as Apn2, in removing these harmful DNA adducts. By understanding these repair mechanisms, the research aims to uncover how cells maintain genomic stability and prevent cell death. This could provide insights into improving cancer treatment outcomes and reducing the side effects of anti-cancer agents.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals exposed to environmental pollutants or undergoing treatment with anti-cancer drugs who may experience DNA damage.

Not a fit: Patients who do not have a history of exposure to environmental toxins or are not undergoing cancer treatment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for enhancing DNA repair mechanisms, potentially reducing the side effects of cancer treatments and improving patient outcomes.

How similar studies have performed: Previous research has shown success in understanding DNA repair mechanisms, but this specific approach focusing on proteolytic repair of DNA-protein crosslinks is relatively novel.

Where this research is happening

San Antonio, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancerAnti-Cancer Agentsanti-cancer drug
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.